Edition:
United Kingdom

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

125.93USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$125.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,126,567
52-wk High
$148.32
52-wk Low
$118.62

Chart for

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $357,562.41
Shares Outstanding(Mil.): 2,684.00
Dividend: 0.84
Yield (%): 2.52

Financials

  JNJ.N Industry Sector
P/E (TTM): 22.53 30.93 32.76
EPS (TTM): 5.91 -- --
ROI: 13.49 15.07 14.61
ROE: 22.63 16.60 16.34

J&J vows to overturn $4.7 billion talc verdict but experts see hurdles

NEW YORK Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri. | Video

13 Jul 2018

Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion (3.55 billion pounds) to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer. | Video

13 Jul 2018

J&J vows to overturn $4.7 billion talc verdict but experts see hurdles

NEW YORK Johnson & Johnson has vowed to appeal a $4.7 billion (£3.5 billion) verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri.

13 Jul 2018

Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.

13 Jul 2018

UPDATE 6-Jury orders J&J to pay $4.7 bln in Missouri asbestos cancer case

July 12 A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.

13 Jul 2018

Jury orders J&J to pay $550 mln in Missouri asbestos cancer case

July 12 A Missouri jury on Thursday found Johnson & Johnson liable in a lawsuit filed by 22 women who alleged the company's talc-based products, including J&J Baby Powder, contain asbestos and caused them ovarian cancer, and ordered the company to pay $550 million in compensatory damages.

12 Jul 2018

Missouri appeals court tosses $55 million J&J talc-powder verdict

A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using talc-based products, including J&J's baby powder, citing a U.S. Supreme court ruling on where such cases can be brought.

30 Jun 2018

Missouri appeals court tosses $55 million J&J talc-powder verdict

A Missouri appeals court on Friday threw out a $55 million (£41.6 million) verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using talc-based products, including J&J's baby powder, citing a U.S. Supreme court ruling on where such cases can be brought.

29 Jun 2018

UPDATE 1-Missouri appeals court tosses $55 mln J&J talc-powder verdict

June 29 A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using talc-based products, including J&J's baby powder, citing a U.S. Supreme court ruling on where such cases can be brought.

29 Jun 2018

Missouri appeals court tosses $55 mln J&J talc-powder verdict

NEW YORK, June 29 A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using its talc-based products, including J&J's Baby Powder, for feminine hygiene.

29 Jun 2018

Earnings vs. Estimates